Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
7S)-N-tert-butyl-3-(2
and apoptotic ratio compared with those in the IR+Mel group
Bethesda (MD): National Center for Biotechnology Information (US)
CN1N=NN=C1SCC1CS[C@@H]2[C@H](NC(=O)[C@H](O)C3=CC=CC=C3)C(=O)N2C=1C([O-])=O
isolated from the bacterium Streptomyces peucetius var
Ranolazine-d8 H-PEG4-CH2COOH 7S)-N-tert-butyl-3-(2Ranolazine d8 (CVT 303 d8) is the deuterium labeled Ranolazine. Ranolazine (CVT 303) is an anti angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 M and 12 M, respectively) without affecting heart rate or blood pressure (BP). Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor. Antianginal agent. Product information CAS Number: 1092804 88 0 Molecular Weight: 435.
US$ 190.00
US$ 190.00
US$ 475.00
US$ 472.50